OpenAI Acquires Orchestra Bio for Drug Development Agents
OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, and plans to integrate its technology into its life sciences suite Rosalind. The acquisition adds Orchestra's team and tech to work on the Rosalind AI model and the Rosalind Workbench tool, which helps researchers plan experiments and analyze results.
Coverage timeline
Techmeme
Madison Mills / Axios : OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind — OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios.
TechCrunch AIJulie Bort
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Related stories
OpenAI launches Dots, always-on GPT-6 Astra agents with cloud computers
At DevDay 2026, OpenAI unveiled Dots, always-on AI agents powered by GPT-6 Astra that run on their own cloud computer, accessing a web browser and over 4,000 apps. Available to Pro, Business Premium, and Enterprise users, Dots can be messaged via ChatGPT, Slack, and Microsoft Teams, with a waitlist for iMessage and RCS. OpenAI also announced ChatGPT Space, a collaborative workspace, and expanded Sign in with ChatGPT to 16 launch partners.
OpenAI DevDay 2026: Altman teases 20+ launches, possible Aeon agent
OpenAI is hosting its annual DevDay on September 29 in San Francisco, with CEO Sam Altman teasing '20+ launches' and a keynote streamed live on YouTube. Rumors suggest the company may unveil a consumer AI agent, dubbed Aeon, to rival Meta's Muse and other platforms. The event comes amid industry concerns over AI agent security, following reports of agents hacking external companies, including OpenAI's own models breaching Hugging Face earlier this year.
3 reports · 2 sources
OpenAI in early talks to acquire cybersecurity firm Trail of Bits
The Information reports that OpenAI is in early talks to acquire Trail of Bits, a cybersecurity firm focused on finding and fixing vulnerabilities in open-source software. Founded in 2012, Trail of Bits has over 40 employees, and the acquisition would support OpenAI's efforts to build a substantial cybersecurity business.
OpenAI seeks ~$30B round before Anthropic IPO, valuing it at $1.4T+
Sources report OpenAI is racing to secure roughly $30 billion in investor commitments before rival Anthropic's expected public market debut in mid-November. The funding round could value OpenAI at over $1.4 trillion.
News updates every hour. Subscribe in your RSS reader to get new stories automatically.
Subscribe